This site is currently implementing core features and is not ready for patient use yet.
This site is currently implementing core features and is not ready for patient use yet.
Biotech company focusing on next-generation vaccines
Founded in 1987, Novavax develops next-generation protein-based vaccines using recombinant nanoparticle technology, including candidates for COVID-19, influenza, and RSV.
No data available
No FAQ items available.